Historical Stock Price
MRNS historical stock prices picture
Marinus Pharmaceuticals (MRNS) has the following price history information. Looking back at MRNS historical stock prices for the last five trading days, on April 16, 2024, MRNS opened at $1.32, traded as high as $1.65 and as low as $1.11, and closed at $1.20. Trading volume was a total of 22.20M shares. On April 17, 2024, MRNS opened at $1.23, traded as high as $1.54 and as low as $1.16, and closed at $1.44. Trading volume was a total of 10.37M shares. On April 18, 2024, MRNS opened at $1.46, traded as high as $1.53 and as low as $1.17, and closed at $1.41. Trading volume was a total of 4.84M shares. On April 19, 2024, MRNS opened at $1.41, traded as high as $1.55 and as low as $1.37, and closed at $1.38. Trading volume was a total of 2.62M shares. On April 22, 2024, MRNS opened at $1.38, traded as high as $1.50 and as low as $1.35, and closed at $1.48. Trading volume was a total of 3.25M shares.

MRNS Historical Stock Prices By Date:

MRNS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Marinus Pharmaceuticals shares, starting with a $10,000 purchase of MRNS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/01/2014
End date: 04/22/2024
Start price/share: $32.00
End price/share: $1.48
Dividends collected/share: $0.00
Total return: -95.39%
Average Annual Total Return: -27.11%
Starting investment: $10,000.00
Ending investment: $460.84
Years: 9.73
Date Open High Low Close Volume
04/16/2024 $1.32 $1.65 $1.11 $1.20 22.20M
04/17/2024 $1.23 $1.54 $1.16 $1.44 10.37M
04/18/2024 $1.46 $1.53 $1.17 $1.41 4.84M
04/19/2024 $1.41 $1.55 $1.37 $1.38 2.62M
04/22/2024 $1.38 $1.50 $1.35 $1.48 3.25M
Marinus Pharmaceuticals is a pharmaceutical company focused on the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus. The U.S Food and Drug Administration approved the use of ZTALMY (ganaxolone) oral suspension for the treatment of seizures associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder in patients two years of age and older. Co. is developing ganaxolone in formulations for two different routes of administration: intravenous (IV) and oral. Ganaxolone is a synthetic analog of allopregnanolone, an endogenous neurosteroid.
Date Close
04/16/2024$1.20
04/17/2024$1.44
04/18/2024$1.41
04/19/2024$1.38
04/22/2024$1.48
MRNS is categorized under the Healthcare sector; below are some other companies in the same sector:

MRSN Historical Stock Prices
MRTX Historical Stock Prices
MSON Historical Stock Prices
MSTX Historical Stock Prices
MTEM Historical Stock Prices
MTNB Historical Stock Prices
MWIV Historical Stock Prices
MYG Historical Stock Prices
MYGN Historical Stock Prices
MYL Historical Stock Prices

Also explore: MRNS shares outstanding history

Email EnvelopeFree MRNS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


MRNS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.